Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04003805 · ClinicalTrials.gov registry record · Phase 1
Biomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) Users
A Phase 1 study of Smoking, Cigarette, sponsored by Masonic Cancer Center, University of Minnesota.
- Active
- Registry status
- Phase 1
- Development phase
- 47
- Enrollment target
- 1
- Study location
NCT04003805 is a Phase 1 study of Smoking, Cigarette that is active but no longer recruiting, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 47 participants, below the 532-participant average among 21 other Smoking, Cigarette trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04003805, a Phase 1 study of Smoking, Cigarette, is active but no longer recruiting, sponsored by Masonic Cancer Center, University of Minnesota.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 47 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is focused on characterizing the toxic and carcinogenic potential of the Standardized Research E-cigarette (SREC) developed by the National Institute on Drug Abuse. In the environment of continuously changing e-cigarette market, SREC was developed as a model e-cigarette that will remain available for an extended period of time and can be used as a bridging element in various studies aimed at evaluating the value and limitations of e-cigarettes as tobacco risk reduction tools. Our overall goal is to generate initial reference data on chemical exposures and associated effects in smokers switching to SREC.
Conditions Studied
Interventions
- DRUG Standardized Research E-cigarette (SREC)
Study Locations (1)
Minnesota
- University of Minnesota, Masonic Cancer Center - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2022-05-11 |
| Est. Completion | 2026-05-20 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04003805
The ClinicalTrials.gov registry entry for NCT04003805 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 532-participant average among 21 other Smoking, Cigarette trials with a reported enrollment target (91% lower). The listed sponsor is Masonic Cancer Center, University of Minnesota, which has 249 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Smoking, Cigarette appearing as the primary indexed condition, and to 1 intervention - of which Standardized Research E-cigarette (SREC) is the first listed.
NCT04003805 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT04003805 about?
NCT04003805 is a clinical study titled "Biomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) Users". This study is focused on characterizing the toxic and carcinogenic potential of the Standardized Research E-cigarette (SREC) developed by the National Institute on Drug Abuse. In the environment of continuously changing e-cigarette market, SREC was developed as a model e-cigarette that will remain a...
What is the current status of trial NCT04003805?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 47 participants. The study started on 2022-05-11. Estimated completion is 2026-05-20.
What conditions does trial NCT04003805 study?
This clinical trial studies the following conditions: Smoking, Cigarette.
What interventions are being tested in trial NCT04003805?
The interventions under investigation include: Standardized Research E-cigarette (SREC) (DRUG).
Who is sponsoring clinical trial NCT04003805?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04003805 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking, Cigarette
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Imaging Sex Differences in Smoking-Induced Pulmonary Inflammation
RECRUITING · Phase 1
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study
RECRUITING
-
Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in Appalachia
RECRUITING · NA
-
Optimizing Tobacco Treatment Delivery for People Living With HIV
RECRUITING · NA
-
Trauma-Informed Care for Smoking Cessation for Pregnancy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.